CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Bertrand LEBOUCHE

OPENALEX: A5030220342↗ORCID: 0000-0002-1273-9393↗

Affiliations

Organizations

McGill Universityauthorship · CA McGill University Health Centreauthorship · CA

Public evidence

3 connected articles

Feasibility of a Randomized, Interventional Pilot Clinical Study of Oral Cannabinoids in People with HIV on Antiretroviral Therapy: CTNPT 028.2024 · Europe PMC Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028).2022 · Europe PMC Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation.2019 · Europe PMC

Registered research

Connected studies

Cannabinoids in People Living With HIV on Effective Antiretroviral Therapy: A Pilot Study to Assess Safety, Tolerability and Effect on Immune Activationnct03550352 In Vitro Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseasesnct06842316

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.

Bertrand LEBOUCHE - Medical Cannabis Research Engine